Your browser doesn't support javascript.
loading
Extracellular heat shock proteins and cancer: New perspectives.
Albakova, Zarema; Siam, Mohammad Kawsar Sharif; Sacitharan, Pradeep Kumar; Ziganshin, Rustam H; Ryazantsev, Dmitriy Y; Sapozhnikov, Alexander M.
Affiliation
  • Albakova Z; Department of Biology, Lomonosov Moscow State University, 199192 Moscow, Russia. Electronic address: zarema.albakova14@gmail.com.
  • Siam MKS; Department of Pharmacy, BRAC University, 1212 Dhaka, Bangladesh.
  • Sacitharan PK; The Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United Kingdom; Department of Biological Sciences, Xi'an Jiaotong-Liverpool University, Suzhou, China.
  • Ziganshin RH; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, 117997 Moscow, Russia.
  • Ryazantsev DY; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, 117997 Moscow, Russia.
  • Sapozhnikov AM; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, 117997 Moscow, Russia.
Transl Oncol ; 14(2): 100995, 2021 Feb.
Article in En | MEDLINE | ID: mdl-33338880
Heat shock proteins (HSPs) are a large family of molecular chaperones aberrantly expressed in cancer. The expression of HSPs in tumor cells has been shown to be implicated in the regulation of apoptosis, immune responses, angiogenesis and metastasis. Given that extracellular vesicles (EVs) can serve as potential source for the discovery of clinically useful biomarkers and therapeutic targets, it is of particular interest to study proteomic profiling of HSPs in EVs derived from various biological fluids of cancer patients. Furthermore, a divergent expression of circulating microRNAs (miRNAs) in patient samples has opened new opportunities in exploiting miRNAs as diagnostic tools. Herein, we address the current literature on the expression of extracellular HSPs with particular interest in HSPs in EVs derived from various biological fluids of cancer patients and different types of immune cells as promising targets for identification of clinical biomarkers of cancer. We also discuss the emerging role of miRNAs in HSP regulation for the discovery of blood-based biomarkers of cancer. We outline the importance of understanding relationships between various HSP networks and co-chaperones and propose the model for identification of HSP signatures in cancer. Elucidating the role of HSPs in EVs from the proteomic and miRNAs perspectives may provide new opportunities for the discovery of novel biomarkers of cancer.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Oncol Year: 2021 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Oncol Year: 2021 Document type: Article Country of publication: United States